RAD51 GENOTYPE AND TRIPLE-NEGATIVE BREAST CANCER (TNBC) RISK IN POLISH WOMEN

被引:22
|
作者
Smolarz, Beata [1 ]
Zadrozny, Marek [2 ]
Duda-Szymanska, Joanna [1 ,3 ]
Makowska, Marianna [4 ]
Samulak, Dariusz [5 ,6 ,7 ]
Michalska, Magdalena M. [5 ]
Mojs, Ewa [8 ]
Brys, Magdalena
Forma, Ewa [9 ]
Romanowicz-Makowska, Hanna [1 ]
机构
[1] Inst Polish Mothers Mem Hosp, Dept Pathol, Mol Genet Lab, PL-93338 Lodz, Poland
[2] Inst Polish Mothers Mem Hosp, Dept Oncol, PL-93338 Lodz, Poland
[3] Med Univ Lodz, Dept Pathol, Lodz, Poland
[4] Reg Hosp, Lodz, Poland
[5] Reg Hosp, Dept Obstet & Gynaecol, Kalisz, Poland
[6] Poznan Univ Med Sci, Cathedral Mothers & Childs Hlth, Poznan, Poland
[7] Poznan Univ Med Sci, Clin Gynaecol Surg, Poznan, Poland
[8] Poznan Univ Med Sci, Dept Clin Psychol, Poznan, Poland
[9] Univ Lodz, Dept Cytobiochem, PL-90131 Lodz, Poland
关键词
triple-negative breast cancer; RAD51; gene; single nucleotide polymorphism; SINGLE NUCLEOTIDE POLYMORPHISMS; RECOMBINATION REPAIR GENES; DNA-REPAIR; HOMOLOGOUS RECOMBINATION; ASSOCIATION; SUSCEPTIBILITY; XRCC3;
D O I
10.5114/PJP.2013.34602
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The most lethal damage for the cell among all damage is double-strand breaks (DSB) of DNA. DSB cause development of cancer diseases including the triple-negative molecular subtype of breast cancer. The aim of this work was to evaluate the single nucleotide polymorphism -135G>C (rs1801320) of the RAD51 gene encoding DNA repair proteins by homologous recombination (HR) in triple-negative breast cancer (TNBC). We assessed the RAD51 -135G>C polymorphism in 50 women with triple-negative breast cancer and in 50 women from the control group. RAD51 polymorphism was analysed by the PCR-RFLP (restriction fragment length polymorphism) technique. Our results demonstrated a significant positive association between the RAD51 C/C genotype and TNBC, with an adjusted odds ratio (OR) of 5.95 (p = 0.002). The homozygous C/C genotype was found in 68% of breast cancer cases and 20% of controls. The variant 135C allele of RADS/increased TNBC risk. This is the first study linking single nucleotide polymorphisms of the RAD51 gene with TNBC incidence in the population of Polish women. In conclusion, RAD51 polymorphisms may be regarded as predictive factors of triple-negative breast cancer in the female population. Large studies are needed to confirm our findings.
引用
下载
收藏
页码:39 / 43
页数:5
相关论文
共 50 条
  • [1] Metformin overcomes resistance to cisplatin in triple-negative breast cancer (TNBC) cells by targeting RAD51
    Jung Ok Lee
    Min Ju Kang
    Won Seok Byun
    Shin Ae Kim
    Il Hyeok Seo
    Jeong Ah. Han
    Ji Wook Moon
    Ji Hae Kim
    Su Jin Kim
    Eun Jung Lee
    Serk In Park
    Sun Hwa Park
    Hyeon Soo Kim
    Breast Cancer Research, 21
  • [2] Metformin overcomes resistance to cisplatin in triple-negative breast cancer (TNBC) cells by targeting RAD51
    Lee, Jung Ok
    Kang, Min Ju
    Byun, Won Seok
    Kim, Shin Ae
    Seo, Il Hyeok
    Han, Jeong Ah
    Moon, Ji Wook
    Kim, Ji Hae
    Kim, Su Jin
    Lee, Eun Jung
    Park, Serk In
    Park, Sun Hwa
    Kim, Hyeon Soo
    BREAST CANCER RESEARCH, 2019, 21 (01)
  • [3] Triple-negative Breast Cancer: RAD51 Test predicts Platinum Sensitivity
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2022, 82 (03) : 249 - 249
  • [4] Polymorphic Variants in 5′-UTR Regions of the RAD51 Gene are Associated With RAD51 Expression and Triple-Negative Breast Cancer (TNBC): A Case-Control Study
    Al Hamad, Mohammad
    Kussaibi, Haitham
    Alkharsah, Khaled R.
    Alsayyah, Ahmed
    El Shawarby, Mohammed
    Al Tamimi, Dalal
    Alomari, Munther
    Bakshi, Hamid A.
    Tambuwala, Murtaza M.
    Al Zoubi, Mazhar S.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2021, 29 (04) : 270 - 276
  • [5] RAD51 is a biomarker for aggressive disease and racial disparities in triple-negative breast cancer
    Acharya, Ganesh N.
    Mani, Chinnadurai
    Manne, Upender
    Palle, Komaraiah
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (01)
  • [6] Rad51 supports triple negative breast cancer metastasis
    Wiegmans, Adrian P.
    Al-Ejeh, Fares
    Chee, Nicole
    Yap, Pei-Yi
    Gorski, Julia J.
    Da Silva, Leonard
    Bolderson, Emma
    Chenevix-Trench, Georgia
    Anderson, Robin
    Simpson, Peter T.
    Lakhani, Sunil R.
    Khanna, Kum Kum
    ONCOTARGET, 2014, 5 (10) : 3261 - 3272
  • [7] Rad51 inhibition sensitizes breast cancer stem cells to PARP inhibitor in triple-negative breast cancer
    Dong Wang
    Ruikai Du
    Suling Liu
    癌症, 2017, 36 (06) : 245 - 246
  • [8] Rad51 inhibition sensitizes breast cancer stem cells to PARP inhibitor in triple-negative breast cancer
    Wang, Dong
    Du, Ruikai
    Liu, Suling
    CHINESE JOURNAL OF CANCER, 2017, 36
  • [9] RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer
    Liu, Yajing
    Burness, Monika L.
    Martin-Trevino, Rachel
    Guy, Joey
    Bai, Shoumin
    Harouaka, Ramdane
    Brooks, Michael D.
    Shang, Li
    Fox, Alex
    Luther, Tahra K.
    Davis, April
    Baker, Trenton L.
    Colacino, Justin
    Clouthier, Shawn G.
    Shao, Zhi-ming
    Wicha, Max S.
    Liu, Suling
    CLINICAL CANCER RESEARCH, 2017, 23 (02) : 514 - 522
  • [10] Rad51 is involved in PARP inhibitor resistance in triple-negative breast cancer stem cells (TNBCSCs).
    Liu, Yajing
    Martin, Rachel
    Bai, Shoumin
    Wicha, Max
    Liu, Suling
    CANCER RESEARCH, 2013, 73 (08)